Institute Of Liver And Bilary Sciences, New Delhi

The Institute of Liver and Biliary Sciences is built around a single organ system. It is a mono-superspecialty institution for liver, biliary and pancreatic disease, and it runs no MBBS course at all: a doctor reaches it only after a first postgraduate medical degree, and a science graduate only through a research entrance. The Delhi government runs it as a deemed-to-be-university, it stands 28th among the country's medical institutions in NIRF 2025, and it fills its seats through two very different doors depending on the course.

ILBS was established in 2009 by the Government of the National Capital Territory of Delhi as an autonomous institute under the Societies Registration Act, 1860, and the University Grants Commission later granted it deemed-to-be-university status, which is what lets it design its own courses and confer its own degrees instead of affiliating to a parent university. Its stated mission is deliberately narrow: to serve as an international centre for the diagnosis and management of liver and biliary disease and for training and research in hepato-biliary sciences. That single-system focus shapes everything downstream, from the specialties it staffs to the degrees it awards, and on the academic side it carries an 'A' grade from the National Assessment and Accreditation Council.

The teaching here starts at the postgraduate superspecialty level and runs up to doctoral research, so the prospectus lists no MBBS, BDS or any first medical degree. The degree courses are three-year superspecialty programmes in hepatology, pancreato-biliary surgery, transplant anaesthesia and pediatric hepatology, sitting alongside a five-year PhD, one-year post-doctoral certificate courses (PDCC), post-graduate certificate courses (PGCC), a fellowship and short certificate courses.

Fees at ILBS are set per course family rather than as one headline figure, and they climb with the course. A PhD or a certificate course totals Rs 38,000 payable at admission, a PGCC Rs 45,000, and a PDCC or fellowship Rs 80,000, while PhD Nursing sits at Rs 60,000 and the six-month Certificate Course in Biostatistics at Rs 35,000. The DM, MCh and DNB-SS superspecialty seats are stipendiary posts filled through national counselling, so their fee is notified there rather than in this table.

Inside each total sits the tuition, which runs from Rs 3,000 a year for a standard PhD to Rs 45,000 for a PDCC, fellowship or PhD Nursing, and Rs 20,000 for a PGCC, on top of a Rs 5,000 yearly library fee, a one-time exit examination fee and a refundable caution deposit. The non-refundable application fee is separate, at Rs 5,000 for PDCC and fellowship, Rs 2,500 for PGCC, and Rs 1,000 for PhD and certificate courses.

Two admission systems run in parallel here, and which one applies depends entirely on the course. The superspecialty DM, MCh and DNB-SS seats are filled through NEET-SS, the national superspecialty entrance, so a candidate for DM Hepatology needs an MD in general medicine or pediatrics first, and one for the MCh in hepato-pancreato-biliary surgery needs an MS in general surgery, with the seat then allotted on NEET-SS merit.

Everything else, the PhD, PDCC, PGCC, fellowship and certificate courses, is admitted on the institute's own all-India entrance. A candidate applies online, then sits a 90-minute paper of 100 multiple-choice questions that carries 70% of the weight, with a 50% qualifying bar, before a departmental assessment and interview worth the other 30% and a final director's interview. The entrance runs twice a year, on the last Sunday of May and the second Sunday of December, feeding the July and January sessions, and the upper age limit for these courses is forty years, relaxed by five years for SC and ST candidates. Short-term training and clinical fellowships take a different path again, with no entrance test at all and a rolling application through the institute's online training portal.

There is no single cutoff to quote for ILBS, and no NEET-UG figure exists because the institute admits no undergraduate batch. For the DM, MCh and DNB-SS seats, the number that decides entry is the NEET-SS closing rank in each specialty, and that moves every year with how far the counselling merit list reaches, so a hepatology seat and a nephrology seat can close hundreds of ranks apart in the same round. For the institute's own PhD, PDCC and certificate entrance, there is no published closing rank at all; the only fixed bar is the 50% qualifying mark in the theory paper, after which the departmental assessment and interview settle the order. A prospective applicant should read the specialty-wise NEET-SS result for the superspecialty seats, and treat the 50% theory threshold as the real gate for the research and certificate courses.

ILBS is a training institute for superspecialists, not a campus that runs a recruitment week, so its outcomes are best read through where its graduates practise rather than through a placement package. Its DM hepatologists, MCh hepato-pancreato-biliary surgeons and transplant-trained anaesthetists move into liver units and transplant programmes across the country, and the institute retains a share of each cohort as senior residents and faculty on its own wards. During training itself, candidates draw a monthly stipend under institute rules, paid across the 36 months of a DM or MCh and the 12 months of a PDCC or PGCC. No ILBS document reports a placement rate or a starting salary for these cohorts, and a package number carried over from a third-party listing that the institute never issued would not survive scrutiny.

The superspecialty intake at ILBS is small and specialty-specific, which is what a mono-organ institute looks like on paper. The prospectus sets 24 degree seats in all across its five NEET-SS programmes, with hepatology taking the largest share.

The PhD, PDCC, PGCC and certificate courses each carry their own small intake, many of the PDCC seats reserved partly for sponsored in-service candidates, and the exact vacancies open in a given cycle are listed in the institute's academic advertisement rather than fixed year to year.

NIRF 2025 placed ILBS 28th among medical institutions in India, with an overall score of 59.22, and that is a climb from the 34th place it recorded in NIRF 2024. The shape of its score fits a small, research-and-treatment institute: it is strongest on teaching, learning and resources, where a low student-to-clinician ratio helps, and thinner on the perception measure, where a niche liver institute is always going to trail the big general medical colleges that a wider public recognises. Away from the ranking tables it holds a NAAC 'A' grade, so its standing rests on clinical depth and research output in a single field rather than on breadth.

The department structure at ILBS mirrors its clinical mission almost one to one, so instead of broad faculties it runs units built around parts of liver and biliary care. Hepatology and hepato-pancreato-biliary surgery sit at the centre, supported by organ transplant anaesthesia and critical care, pediatric hepatology, and nephrology on the clinical side. Around them are the diagnostic and research departments the institute trains through its certificate courses: clinical and diagnostic virology, hepatopathology, transfusion medicine and blood banking, clinical microbiology, gastro and interventional radiology, GI medical oncology, and laboratory departments in clinical biochemistry and molecular and cellular medicine. That spread is narrow by the standards of a general medical college but unusually deep within the hepato-biliary field.

The teaching happens inside a working superspecialty hospital rather than a separate college block. ILBS describes itself as a mono-superspecialty tertiary-care hospital with a sanctioned strength of 549 beds, of which more than 300 are operational, served by four operation theatres, a round-the-clock emergency, a blood bank, a pathology laboratory, a radiology department and a dedicated research centre. Because the whole institution is pointed at one organ system, that infrastructure is concentrated, with imaging, pathology and interventional services tuned to liver and biliary work rather than spread across every discipline. The campus at Vasant Kunj combines the hospital, the academic block and residential accommodation on a single site.

Residence at ILBS is not an option a student can decline. The prospectus is explicit that the institute is a fully residential complex and that all residents must live on the campus compulsorily for the duration of their course, which suits an institution whose trainees are expected on the wards through the day and often at night. Hostel charges are billed under institute rules, and because on-campus residence is mandatory rather than first-come, an admitted candidate settles accommodation as part of joining rather than applying for it separately.

ILBS is led as a university, with a Chancellor, Vice-Chancellor, Dean and Registrar rather than a single principal. Its founding figure and Chancellor is Professor S.K. Sarin, the hepatologist around whose work the institute was built, and the academic office runs through the Dean and a Controller of Examinations. The clinical faculty are superspecialists in hepatology, hepato-pancreato-biliary surgery, transplant medicine and the supporting diagnostic sciences, and with no undergraduate cohort to teach, their effort goes entirely into treating patients and supervising DM, MCh and PhD trainees. The institute does not publish a single consolidated faculty headcount, so we describe the structure rather than assert a number we cannot source.

The institute is young and its graduating cohorts are small and recent, so a credible alumni record is harder to stand behind here than at a long-established college, and we would rather leave this section honest than fill it with names we cannot confirm.

The item most worth watching at ILBS is the admission cycle itself, because its dates move through the year. The institute issues its admission notifications in print and on its website in March and September, ahead of entrance exams held on the last Sunday of May and the second Sunday of December, and it lists the exact vacancies for a cycle in a numbered academic advertisement rather than a fixed annual figure. For anything time-sensitive, the institute's own notice board and advertisement are the source to trust over any third-party calendar.

Comparing ILBS with a general medical university is close to a category error, and seeing why sharpens what it is. A broad institute such as AIIMS New Delhi runs the full range from MBBS upward across every discipline; ILBS runs no MBBS and no general specialties, and instead pushes a single organ system to superspecialty and doctoral depth. Set an MBBS fee sheet or a NEET-UG opening rank next to ILBS and both columns stay empty, because the institute sells no undergraduate seat and publishes no undergraduate cutoff. The fairer comparison is with other hepatology and transplant centres on the specific ground that matters: the DM and MCh branches each one teaches, its NEET-SS closing ranks by specialty, and its transplant and research volumes.

ILBS occupies a single campus at D-1, Vasant Kunj, New Delhi 110070, with an academic office reachable on +91-11-46300000 that handles course and admission queries. The form is completed on ilbs.in itself, and ILBS accepts no walk-in or postal submission.

At a glance

Quick facts